Showing 4,181 - 4,200 results of 4,278 for search '(( significantly mean decrease ) OR ( significantly impaired decrease ))', query time: 0.30s Refine Results
  1. 4181

    Data Sheet 7_Effects of aging on otolith morphology and functions in mice.xlsx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  2. 4182

    Data Sheet 5_Effects of aging on otolith morphology and functions in mice.xlsx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  3. 4183

    Data Sheet 4_Effects of aging on otolith morphology and functions in mice.xlsx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  4. 4184

    Data Sheet 3_Effects of aging on otolith morphology and functions in mice.xlsx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  5. 4185

    Data Sheet 8_Effects of aging on otolith morphology and functions in mice.xlsx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  6. 4186

    Data Sheet 1_Effects of aging on otolith morphology and functions in mice.docx by Keita Ueda (19855536)

    Published 2024
    “…Background<p>Increased fall risk caused by vestibular system impairment is a significant problem associated with aging. …”
  7. 4187

    Data Sheet 1_The relationship between hearing loss and frailty in older adults at risk of cognitive decline: a cross-sectional study.pdf by Rong Tian (397491)

    Published 2025
    “…Objectives<p>To investigate the association between hearing loss and frailty among a group of older community volunteers with mild cognitive impairment.</p>Design<p>This study recruited 162 older community volunteers who have mild cognitive impairment and symmetric age-related hearing loss. …”
  8. 4188

    Image 1_Cerebellar microstructural and functional connectivity changes in patients with neuromyelitis optica spectrum disorders and their correlation with cognitive function: a fem... by Yingyu Zhang (7846409)

    Published 2025
    “…</p>Results<p>Patients exhibited significant cerebellar alterations, including GMV reduction in bilateral lobules VI/VIII and the vermis, decreased fractional anisotropy in Crus I, and altered FC between Crus I and occipital/frontal regions. …”
  9. 4189

    Image 3_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

    Published 2025
    “…Additionally, 10 patients showed decreased cytokine levels.Importantly, tocilizumab did not impair CAR-T cell expansion or efficacy, nor did it increase the incidence of adverse events.…”
  10. 4190

    Table 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.docx by Qianyi Zhou (6196383)

    Published 2025
    “…Additionally, 10 patients showed decreased cytokine levels.Importantly, tocilizumab did not impair CAR-T cell expansion or efficacy, nor did it increase the incidence of adverse events.…”
  11. 4191

    Image 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

    Published 2025
    “…Additionally, 10 patients showed decreased cytokine levels.Importantly, tocilizumab did not impair CAR-T cell expansion or efficacy, nor did it increase the incidence of adverse events.…”
  12. 4192

    Table 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.doc by Qianyi Zhou (6196383)

    Published 2025
    “…Additionally, 10 patients showed decreased cytokine levels.Importantly, tocilizumab did not impair CAR-T cell expansion or efficacy, nor did it increase the incidence of adverse events.…”
  13. 4193

    Image 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

    Published 2025
    “…Additionally, 10 patients showed decreased cytokine levels.Importantly, tocilizumab did not impair CAR-T cell expansion or efficacy, nor did it increase the incidence of adverse events.…”
  14. 4194

    Data Sheet 1_Breaking the cycle: a pilot study on autonomous Digital CBTe for recurrent binge eating.pdf by Rebecca Murphy (5514419)

    Published 2025
    “…Those who completed all sessions and the post-intervention assessment (n = 55, 50%) reported significant decreases in binge eating, eating disorder psychopathology, and secondary impairment at post-intervention. …”
  15. 4195

    Table 2_Analysis of risk factors in breast cancer patients with hand-foot syndrome and oral mucositis caused by pegylated liposomal doxorubicin.doc by Xianghua Quan (21404606)

    Published 2025
    “…However, PLD is associated with adverse reactions (ADRs) such as hand-foot syndrome (HFS) and oral mucositis (OM), which have garnered significant attention. Although not life-threatening, HFS and OM can cause severe discomfort and functional impairment. …”
  16. 4196

    Data Sheet 2_Metabolomics reveals key biomarkers for ischemic stroke: a systematic review of emerging evidence.pdf by Lu Ding (475637)

    Published 2025
    “…Glycine-serine-threonine and valine-leucine-isoleucine pathways were significant in diagnosing IS and AIS, and in differentiating ischemic and hemorrhagic strokes, as well as identifying post-stroke depression and cognitive impairment.…”
  17. 4197

    Data Sheet 1_Metabolomics reveals key biomarkers for ischemic stroke: a systematic review of emerging evidence.pdf by Lu Ding (475637)

    Published 2025
    “…Glycine-serine-threonine and valine-leucine-isoleucine pathways were significant in diagnosing IS and AIS, and in differentiating ischemic and hemorrhagic strokes, as well as identifying post-stroke depression and cognitive impairment.…”
  18. 4198

    Table_3_Combinatorial protection of cochlear hair cells: not too little but not too much.docx by Arwa Kurabi (344167)

    Published 2024
    “…They also suggest that inhibiting too many biological processes impairs functions critical to HC survival, resulting in decreased protection.…”
  19. 4199

    Data Sheet 3_Metabolomics reveals key biomarkers for ischemic stroke: a systematic review of emerging evidence.pdf by Lu Ding (475637)

    Published 2025
    “…Glycine-serine-threonine and valine-leucine-isoleucine pathways were significant in diagnosing IS and AIS, and in differentiating ischemic and hemorrhagic strokes, as well as identifying post-stroke depression and cognitive impairment.…”
  20. 4200

    Table_2_Combinatorial protection of cochlear hair cells: not too little but not too much.docx by Arwa Kurabi (344167)

    Published 2024
    “…They also suggest that inhibiting too many biological processes impairs functions critical to HC survival, resulting in decreased protection.…”